BriaCell Therapeutics Corp. (TSX:BCT)
Canada · Delayed Price · Currency is CAD 1.080
-0.020 (-1.82%)
Jul 22, 2025, 1:48 PM EDT
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-1.68M CAD
Market Cap
7.45M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jul 31, 2023 | 16 | 10 | 166.67% |
| Jul 31, 2021 | 6 | 0 | - |
| Aug 1, 2019 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Green Thumb Industries | 4,800 |
| Sienna Senior Living | 12,263 |
| dentalcorp Holdings | 10,200 |
| WELL Health Technologies | 1,507 |
| Extendicare | 23,000 |
| Cronos Group | 459 |
| Trulieve Cannabis | 6,000 |
| Curaleaf Holdings | 5,519 |
BriaCell Therapeutics News
- 5 days ago - BriaCell Therapeutics Announces Closing of $15 million Public Offering - GlobeNewsWire
- 6 days ago - BriaCell Therapeutics Announces Pricing of $15 million Public Offering - GlobeNewsWire
- 7 days ago - BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer - GlobeNewsWire
- 11 days ago - BriaCell's Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer - GlobeNewsWire
- 12 days ago - BriaCell Reports Complete and Sustained Resolution of Brain Metastasis and Sustained Regression of Orbital Metastasis in “Eye-Bulging” Breast Cancer Patient - GlobeNewsWire
- 13 days ago - BriaCell Patient Achieves Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Metastatic Breast Cancer Study - GlobeNewsWire
- 14 days ago - BriaCell Phase 2 Survival Achievement: 52% of Patients Surpass One-Year Milestone in Metastatic Breast Cancer - GlobeNewsWire
- 20 days ago - BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven - GlobeNewsWire